Ozempic manufacturer Novo Nordisk faces challenges as the patent on semaglutide expire in one country after the other.

Ozempic manufacturer Novo Nordisk faces challenges as the patent on semaglutide expire in one country after the other.

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.